|
|
#1
07-18-2016, 06:23 AM
|
|||
|
|||
Samsung Bioepis seeks Europe approval for its Humira copy
SEOUL (Reuters) - Biosimilars maker Samsung Bioepis, part of South Korea's top family-run conglomerate Samsung Group [SAGR.UL], said on Monday it is seeking regulatory approval in Europe to sell its copy of AbbVie Inc's rheumatoid arthritis drug Humira. ??????? ??????: Samsung Bioepis seeks Europe approval for its Humira copy || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
